Non-Muscle-Invasive Bladder Cancer Management Post-BCG Therapy | BackTable Urology Clips

Dr. Bagrodia, Dr. Clinton and Dr. Pietzak discuss the management of high-grade non-invasive bladder cancer following initial BCG (Bacillus Calmette-Guérin) therapy. They explore various treatment options, including a second induction course of BCG, the possibility of radical cystectomy, and alternative intravesical therapies such as gemcitabine and docetaxel. They focus on the criteria for BCG-unresponsive disease, patient concerns, and the importance of early and transparent communication about treatment plans, potential outcomes, and available clinical trials.

Watch the full episode on non-muscle-invasive bladder cancer: Management of BCG-refractory NMIBC w/...

#bladdercancer #urologysurgery #urooncology #URO64 #backtableclips

• #science_technology
• #bcg_administration
• #bcg_intolerance
• #bcg_unresponsive
• #t1_high_grade
• #bladder_cancer
• #clinical_trials
• #cystectomy
• #immunotherapy
• #systemic_side_effects
• #tumor_resection
• #bacillus_calmette_gurin
• #dr_aditya_bagrodia
• #dr_eugene_pietzak
• #dr_tim_clinton
• #non_muscle_invasive_bladder_cancer
• #radical_cysectomy